NCT06344845View on ClinicalTrials.gov

Clinical Study of [18F] PM-PBB3 PET Imaging of Tau Protein in Neurodegenerative Diseases

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2025

Conditions
Neurodegenerative Diseases
Interventions
DIAGNOSTIC_TEST

18F-PBB3 PET/CT scan

Patients with suspected neurodegeneration underwent PET/CT scan after injection of 370MBq (10 mCi)18F-FDG to observe for TAU deposition.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER